Posters

Poster Area

Posters will be presented in the Poster Area, which is located on the ground floor. (see floor plan, page 84)

Posters

Posters will be presented on poster boards from Sunday, November 11 until Tuesday, November 13. Presenters are requested to be available for discussion of their posters on the day of their presentation coffee, tea and lunch breaks.

Topic	No’s on display
Transfusion Transmittable Infections	P-001 - P-042
Blood Supply Management	P-043 - P-044
Basics and Clinical Application in Cell Therapy	P-045 - P-052
Transfusion Transmittable Emerging Infections	P-053
Red Cell Blood Groups	P-054 - P-074
Models of Increased Safety Measures	P-075 - P-082
Expanding the Role of Blood Banks / Hospitals	P-083 - P-084
Platelets Transfusion	P-085 - P-104
Blood Donor Recruitment	P-105 - P-114
Transfusion Practice in Specific Clinical Situations	P-115 - P-129
Topic Safety of Cells and Tissues and its Donors	P-130 - P-133
Haemovigilance in Patients	P-134 - P-136
Quality Management	P-137 - P-140
Hemophilia	P-141 - P-144
New Trends in Transfusion Medicine Science	P-145 - P-147
Late Submitted Abstracts	P-148 - P-157

Poster Mounting

Please mount your poster on Sunday November 11, between 08.00 and 10.00 hours. The number of your poster can be found in the final programme and/or abstract book which will be handed over to upon registration. There is a poster desk in the poster area. The staff at this desk can help you to mount your poster. Assistance and materials for mounting the posters (tape, blue tack, etc.) will be available. Setting-up a poster generally takes at least 15 minutes.

Poster Removing

Posters should be taken on Tuesday, November 13 before 12.00 hours. According to the schedule. Posters that have not been taken down by the author(s) in time will be removed and destroyed.
Responsibility for Poster Presentations The Local Organising Committee nor the ISBT does not assume any responsibility for material displayed on the poster boards.

Topics

Transfusion Transmittable Infections

P-001 THE TREND OF HEPATITIS B SEROCONVERSION IN REGULAR BLOOD DONORS AT THE UNIT OF TRANSFUSION MEDICINE-HUSM

S.A. Ahmed, R. Hasan, T.M. Roshan, R. Mustafa, H. Mohammed (University of Science of Malaysia, Kota Bharu, Malaysia)

P-002 POSITIVE PREDICTABILITY OF THE THIRD GENERATION ANTI-HEPATITIS C VIRUS (HCV) ELISA TESTS FOR HCV INFECTION IN BLOOD DONORS

S. Amini Kafi-Abad, M. Shariati, A. Talebian (Research Center-Iranian Blood Transfusion, Tehran, Iran)

P-003 TREND OF HEPATITIS B SURFACE ANTIGEN (HBSAG) AMONG BLOOD DONORS IN HIGH AND LOW PREVALENCE REGIONS IN IRAN, MARCH 1997 - MARCH 2006

S. Amini Kafi-Abad, A. Soleimany, M. Shariati, A. Talebian (Research Center-Iranian Blood Transfusion, Tehran, Iran)

P-004 IMPLICATION ARISING FROM A SEPTIC CASE OF STAPHYLOCOCCUS AUREUS WITH TRANSFUSION OF PLATELET CONCENTRATE

T. Ando, M. Uruma, H. Kato, Q.N. Tung, R. Niwa, A. Katai, A. Takao, M. Hayashi, M. Asai, M. Ito, M. Nitta, S. Takamoto (Aichi Medical University, Aichi, Japan)

P-005 SOLVENT DETERGENT-TREATED PLASMA: RISK OF TRANSFUSION-TRANSMITTED NON-ENVELOPED VIRUSES

P. Andonov, G. Rock, M. Morbey, K. Swidinsky, L. Lin, E. Grudeski, J. Wu (Public Health Agency of Canada, Winnipeg, Canada)

P-006 THE ANALYSIS OF BACTERIAL CONTENT IN PLATELET COLLECTIONS THAT HAVE UNDERGONE LEUKOCYTE REDUCTION WITH APHERESIS

T. Asai, Y. Fujii, H. Ohto (Japanese Red Cross, Shizuoka City, Japan)

P-007 SUCCESSFUL FIELD TRIAL RESULTING IN IMPLEMENTATION OF AN IMPROVED METHOD OF DONOR VENEPUNCTURE SITE DISINFECTION

C. Biggs, J. Kellington, L. Batson, C. McDonald (NHS Blood and Transplant, London, United Kingdom)

P-008 IMPORTANCE OF THE UNIFORM DONOR HEALTH QUESTIONNAIRE: CASE REPORT

S. Bogdanovic (Blood Transfusion Institute Vojvodina, Novi Sad, Serbia)

P-009 NUCLEIC ACID TESTING IN MALAYSIA BLOOD PROGRAM; A PILOT STUDY BY NATIONAL BLOOD CENTRE ( NBC ), KUALA LUMPUR

A.H. Bon, T.P. Lam, M. Mat Radzi, N.F. Mohd.Nor, Y.A. Ayob (National Blood Centre, Kuala Lumpur, Malaysia)

P-010 TRANSFUSION TRANSMITTED HEPATITIS B INFECTION: CASE REPORT

N. Bujandric (Blood Transfusion Institute Vojvodina, Novi Sad, Serbia)

P-011 HTLV-1/2 IN A PUBLIC TRANSFUSION CENTER IN BELO HORIZONTE, BRAZIL -ASPECTS OF HEMOVIGILANCE

A.B. Carneiro-Proietti, M.S. Namen-Lopes, M. Lobato Martins, P.C. Drummond, R. Lobato, GIPH Interd HTLV Res Group (Fundação Hemominas, Belo Horizonte, Mg, Brazil)

P-012 EVALUATION OF ROCHE COBAS TAQSCREEN MULTIPLEX TEST ON THE S 201 SYSTEM FOR SCREENING OF DONORS FOR HBV, HCV AND HIV IN TAIWAN

M.H. Chen, L. Li, P.J. Chen, W.P. Chen, M.H. Tsai, S.J. Lin Tsai, K.S. Lin (Taipei Blood Center, Taiwan Blood Servic, Taipei, Taiwan)

P-013 AN ANALYSIS OF EPIDEMIC SITUATION OF HIV/AIDS IN HENAN PROVINCE, CHINA

V. Cui (San Francisco Public Health, San Francisco, USA)

P-014 GENE SEQUENCE AND SUBTYPE ANALYSIS OF HIV STRAINS IN PARTIAL AREA OF HENAN PROVINCE, CHINA

V. Cui (San Francisco Public Health, San Francisco, USA)

P-015 PREVALENCE OF HEPATITIS A VIRUS INFECTION IN BLOOD DONORS

A. Elikaei, Z. Sharifi, M. Mahmoudian Shooshtrari, M. Hosseini, A. Talebian, F. Mahmoudi, Y. Maarufi (Iranian Blood Transfusion Organization, Tehran, Iran)

P-017 TRENDS IN PREVALENCE OF TRANSFUSION-TRANSMISSIBLE VIRAL INFECTIONS IN YAZD BLOOD TRANSFUSION ORGANIZATION

H. Javadzadeh Shahshahani, M. Attar (Research Center of Iranian BTO, Yazd, Iran)

P-018 PREVALENCE OF CHLAMYDIA PNEUMONIAE IN PERIPHERAL BLOOD MONONUCLEAR CELLS BY RT-PCR IN APPARENTLY HEALTHY BLOOD DONORS IN TEHRAN BLOOD TRANSFUSION CENTER

G. Karimi, S. Samiei, A. Gharehbaghian, M. Moslemi, S. Abdoallahi Sabet, M. Mahmoodian Shooshtari, M. Magsudlu, S. Amini Kafiabad, A. Azarkeivan (Research Center of IBTO, Tehran, Iran)

P-019 QUANTITATIVE REAL-TIME PCR ASSAY FOR TRYPANOSOMA CRUZI

T. Lee, L. Montalvo, D. Chafets, P. Doyle, S. Miller, M. Busch (Blood Systems Research Institute, San Francisco, USA)

P-020 SEROPREVALENCE OF HTLV-I/II ANTIBODIES IN KOREAN BLOOD DONORS

A.H. Lim, J.Y. Park, J.Y. Lee, K.W. Youn, S.H. Han, N.S. Cho, S.Y. Kwon (Blood Transfusion Research Institute, Seoul, South-Korea)

P-021 SENSITIVITY OF FOUR NEW HEPATITIS B SURFACE ANTIGEN ASSAYS (ARCHITECT, HEPANOSTIKA ULTRA, MONOLISA ULTRA AND MODULAR II)

T.D. Ly, A.M. Roque-Afonso, A. Servant-Delmas, M. Mercier, V. Fihman, A. Ebel, E. Dussaix, S. Laperche (Laboratory LCL, Ivry-sur-seine, France)

P-022 COMPARED PERFORMANCE BETWEEN WETERN BLOT AND DOT

BLOT TECHNOLOGIES FOR HIV-1 CONFIRMATION

T.D. Ly, V. Fihman, A. Ebel (Laboratory LCL, Ivry-sur-Seine, France)

P-023 PREVALENCE OF PARVOVIRUS B19 INFECTION IN BLOOD DONORS

F. Mahmoudi, M. Mahmoudian Shooshtrari, Z. Sharifi, M. Hosseini, A. Talebian, A. Elikaei, Y. Maarufi (Research Center Of Iranian Blood Transfusion Service, Tehran, Iran)

P-024 OCCULT HEPATITIS B VIRUS INFECTION AMONG ANTI-HB C POSITIVE BLOOD DONORS OF NORTH INDIA

R.N. Makroo, V. Raina, M. Chowdhry, M. Pathuppally (Apollo Hospital, New Delhi, India)

P-025 ANTI-HCV ANTIBODY PRESENCE IN VOLONTEER BLOOD DONORS IN PRILRP

T. Momiroska, E. Kocoska, T. Timova, E. Baseska, V. Jovanoska, T. Ilieska-Nebrezanec (Pablik Hospital, Prilep, Macedonia)

P-026 GEOGRAPHICAL DISTRIBUTION OF HBS AG AMONG HEALTHY VOLUNTEER IRANIAN BLOOD DONORS

M. Mozooni, S. Zolfaghari Anaraki, A. Talebian, M. Borhan Azad (Iranian Blood Transfusion Organization, Tehran, Iran)

P-027 RISK FACTORS FOR CHRONIC HEPATITIS B VIRUS INFECTION AMONG INDIAN BLOOD DONORS

E.L. Murphy, L. Jagannathan, M. Rice, T.K. Doss, E.L. Murphy (University of California San Francisco and BSRI, San Francisco, USA)

P-028 ROLE OF INDONESIAN RED CROSS (IRC) IN REDUCING HIV TRANSMISSION THROUGH LINKED CONFIDENTIAL POLICY IN BLOOD TRANSFUSION SERVICE (BTS) : YOGYAKARTA CASE

R. Nur Aditya (Indonesian Red Cross, Jakarta, Indonesia)

P-029 EFFECTIVENESS OF CONFIDENTIAL UNIT EXCLUSION ON BLOOD SAFETY

A. Omidkhoda, S.H. Sharifi, N. Ahmadbiagy (Iranian Blood Transfusion Center, Tehran, Iran)

P-030 POSITIVE RATE OF TRANSFUSION TRANSMITTED INFECTIOUS IN BLOOD DONORS AT NATIONAL BLOOD CENTRE, THAI RED CROSS SOCIETY; 2002-2006

M. Oota (National Blood Centre, Thai Red Cross, Bangkok, Thailand)

P-031 TRANSFUSION TRANSMITTED DISEASES AMONG BLOOD DONORS IN A CARDIAC HOSPITAL BLOOD BANK IN NEPAL

N. Parajuli, B. Acharya (Shahid Gangalal National Heart Centre, Kathmandu, Nepal)

P-032 CMV INFECTION IN RENAL TRANSPLANT RECIPIENTS IN IRAN F. Ranjbarkermani, Z. Sharifi, A. Talebian, F. Ferdosian, Z. Paz, N. Passandideh

(Research Center of IBTO, Tehran, Iran)

P-033 TRANSFUSION TRANSMITTED INFECTIONS AMONG MULTITRANSFUSED PATIENTS IN IRAN (A REVIEW)

H. Rezvan, H. Abolghasemi, S. Amini Kafiabad (Iranian Blood Transfusion Organisation, Tehran, Iran)

P-034 PREVALANCE OF MALARIAL PARASITE AMONG VOLUNTARY BLOOD DONORS IN KARACHI DURONG JAN 2006 TO DECEMBER 2007,(97916 DONORS) TESTED IN ONE YEAR

Z.Z. Sanji (Husaini Hematology and Oncology Trust, Karachi, Pakistan)

P-035 USE AND VALIDATION OF POOLED HIV, HBSAG AND HCV POSITIVE SERA FOR QUALITY CONTROL IN SCREENING FOR TRANSFUSION TRANSMISSIBLE INFECTION’S IN A BLOOD TRANSFUSION SERVICE

M. Satish (Apollo Health City, Hyderabad, India)

P-036 PREVALENCE OF HIV IN BLOOD DONORS IN NORTHERN INDIA USING FOURTH-GENERATION ENZYME-LINKED IMMUNOSORBENT ASSAY

D. Sen, K. Chatterjee, P. Chand (Armed Forces Transfusion Centre, New Delhi, India)

P-037 IDENTIFICATION OF HCV GENOTYPES IN IRANIAN HCV INFECTED PATIENTS

Z. Sharifi, F. Rangbar Kermani, M. Mahmoudian Shooshtari, F. Ferdocian, Z. Paz, N. Pasandideh, A.R. Talebian (Research Center Of Iranian Blood Transfusion, Tehran, Iran)

P-038 CORRELATION OF HERPES SIMPLEX VIRUS(HSV1&2) IGG, IGM IN HIV POSITIVEITY

F.A. Tarabadi, M. Shaiegan, M. Aghaeipour, G. Babaee (Iranian Blood Transfusion Res. Centre, Tehran, Iran)

P-039 EVALUATION OF SERUM ß2 MICROGLOBULIN (ß2-MG ) LEVELS IN HBSAG POSITIVE AND HIV POSITIVE DONORS

F.A. Tarabadi, M. Shaeigan, G. Babaee, A. Chigini, M. Aghaeipour (Iranian Blood Transfusion Res. Centre, Tehran, Iran)

P-040 PRESENCE OF HBSAG AMONG VOLUNTARY BLOOD DONORS IN THE MUNICIPALITY OF STRUMICA

T. Timova, E. Kocovska, V. Gorgevska, L. Maninska, D. Stambolieva, S. Kostovska (General hospital-Strumica, Strumica, Macedonia)

P-041 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION: A PROMISING NEW APPROACH FOR NAT BLOOD SCREENING

X. Wang, Y. Jia, L. Zheng, X. Wu, K. Qian, J. Yi, Y.M. Zhu (Shanghai Blood Center, Shanghai, China)

P-042 THE PREVALENCE RATE OF HEPATITIS B (HBS AG+) AMONG REPEATED BLOOD DONORS IN TEHRAN BLOOD TRANSFUSION CENTER FROM MAR. 2005 TO MAR. 2006

M. Zadsar (Iranian Blood Transfusion Organisation, Tehran, Iran)

Blood Supply Management

P-043 PREOPERATIVE AUTOLOGOUS BLOOD DONATED AND THE USE OF IT IN MILITARY CENTRAL UNIVERSITY HOSPITAL

N. Borici, E. Berberi, M. Mero, I. Seferi (Central University Military Hospital, Tirana, Albania)

P-044 BLOOD COMPONENT DISCARD RATE IN A GREEK GENERAL HOSPITAL

C. Veneti, V. Tsagkari, D. Peristeraki (Konstantopoulio General Hospital, Athens, Greece)

Basics and Clinical Application in Cell Therapy

P-045 COMPARISON OF MEMBRANE FILTRATION TO CENTRIFUGATION FOR THERAPEUTIC PLASMA EXCHANGE

J.S. Choi, Y.H. Kim, K.S. Han (Seoul National University Hospital, Seoul, South-Korea)

P-046 CHARACTERISATION OF THE BONE MARROW IMMUNOFLUORESCENCE TEST (BMIFT) IN CHILDHOOD AUTOIMMUNE NEUTROPENIA

Y.L. Fung, S. Lane, P. Hassell, G. Kennedy, B. Williams (Australian Red Cross Blood Service, Brisbane, Australia)

P-047 HLA ANTIBODIES DETECTION, ACTIVE IMMUNOTHERAPY AND ANALYSIS BETWEEN COUPLES WITH UNEXPLAINED HABITUAL ABORTION

W.D. Shen (Nan-Ning Institute of Transfusion Med, Nan-ning, China)

P-048 DIFFERENCES IN CIRCULATING DENDRITIC CELL SUBTYPES IN PREGNANT WOMEN, CORD BLOOD AND HEALTHY ADULT WOMEN

E.Y. Song, S. Kim, Y. Yun, K.U. Park, K.S. Han, E.Y. Roh, J.H. Yoon, S. Shin (Konkuk university hospital, Seoul, South-Korea)

P-049 THE EFFECTIVENESS OF ERYTHRAPHERESIS PERFORMED WITH BLOOD SEPARATOR MCS+ IN PATIENTS WITH PRIMARY POLYCYTHAEMIA

A. Uchimiak-Owieczko, B. Boczkowska-Radziwon, P. Radziwon, D. Sredzinski (Regional Centre for Transfusion Medicine, Bialystok, Poland)

P-050 COMPARISON OF COLLECTION OF PERIPHERAL BLOOD STEM CELLS USING COBE SPECTRA AND HAEMONETICS MCS+

F. Wu, K.K. Heng, S. Rohaini, P. Law, Y.T. Goh (Singapore General Hospital, Singapore, Singapore)

P-052 COMPARATIVE STUDY ON THE METHODS OF MICRO-LYMPHOCYTE CYTOTOXIC TEST (MLCT) AND POLYMERASE CHAIN REACTION WITH SEQUENCE SPECIFIC PRIMERS (PCR-SSP) FOR THE DETECTION OF HLA- B27

Y. Zhou, W.D. Shen, Q.H. Mo, H.C. Li, B.R. He (Nan-Ning Institute of Transfusion Med, Nan-Ning, China)

Transfusion Transmittable Emerging Infections

P-053 PREVALENCE OF ANTI-HEPATITIS E VIRUS AMONG JAPANESE BLOOD DONORS

K. Matsubayashi, H. Takeda, H. Sakata, E. Kon, S. Sato, T. Kato, S. Hino, K. Tadokoro, H. Ikeda (Hokkaido Red Cross Blood Center, Sapporo, Japan)

Red Cell Blood Groups

P-054 IRREGULAR ANTIBODIES PREVALENCE IN HEMATOLOGICAL PATIENTS AT NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION (2004-2005)

T.M.A. Bui (NIHBT, Hanoi, Vietnam)

P-055 STUDY ON SOME RED CELL BLOOD GROUP IN O GROUP BLOOD DONOS AT NIHBT TO BUILD UP PANEL CELL FOR SCREENING IRREGULAR ANTIBODIES

T.M.A. Bui, T.M.A. Bui, A.T. Nguyen (NIHBT, Hanoi, Vietnam)

P-056 ABH GLYCOLIPIDS IN HUMAN SPERM: EXPRESSION AND RELATIONSHIP WITH EOSIN TEST

Ch. Chaingam, A.S. Brufman, S.E. Streiger, S.E. Solis, G.M. Garcia Rosasco (Rosario National University, Rosario, Argentina)

P-057 IMPORTANCE OF PHENOTYPING RH-KELL TESTING IN INDIA DONE IN EM-TECHNOLOGY AT AIIMS NEW DELHI INDIA

K.B. Chatterji (AIIMS, New Delhi, India)

P-058 ESTIMATING THE GENETIC DISTANCE AND PROTRACTING THE PHYLOGENETIC TREE BY THE POLYMORPHISM OF MICA TRANSMEMBRANE MICROSATELLITE BETWEEN SOUTH HANS AND DIFFERENT POPULATION IN CHINA

M.L. Feng, T. Shen, D.Z. Liu (Shanghai Blood Center, Shanghai, China)

P-059 STUDY ON THE PATERNITY TESTING CASES OF HEREDITARY ABNORMITY OF ABO GROUP BY SHORT TANDEM REPEATS (STRS) LOCI GENOTYPING

B.R. He, W.D. Shen, Q.M. Tang, H.C. Li, Y. Zhou, Y. Liao, Q.H. Mo, D.Y. Huang, G.G. Wu (Nan-Ning Institute of Transfusion Medici, Nan-ning, China)

P-060 ABO GENOTYPING USING A MULTIPLEX SINGLE-BASE PRIMER EXTENSION REACTION

J. Hyun, H.E. Chang, S.R. Heo, S.H. Song, K.U. Park, J. Song, K.S. Han (Seoul National Univ. College of Medicine, Seoul, South-Korea)

P-061 ANALYSIS OF THE RELATIONSHIP BETWEEN RH TYPING AND THE GENERATION OF ANTI-D ANTIBODY IN CHINESE RHD NEGATIVE POPULATION IN SHANGHAI AREA

S. Jin, D. Xiang, X.H. Cai, Q. Li, X. Liu, J.L. Wang, W. Shen, Q. Lu (Shanghai Blood Center, Shanghai, China)

P-062 A SHORT TIME (30 MINUTES) METHOD FOR PRETRANSFUSION RED CELL TESTING BY OLYMPUS PK7300

T. Kato, K. Ishimaru, W. Ohashi, S. Sato, H. Ikeda (Hokkaido Red Cross Blood Center, Sapporo, Japan)

P-063 INCIDENCE OF RED CELL ALLOANTIBODY IN PATIENTS WHO RECEIVED BLOOD AT BAMRASNARADURA INFECTIOUS DISEASE INSTITUTE

K. Kohreanudom (Maharaj Nakhonsrithammarat Hospital, Nakhonsrithammarat, Thailand)

P-064 PERFORMANCE AND CLINICAL SIGNIFICANCE OF SIMULTANEOUS TESTING BY LISS/COOMBS AND NACL/ENZYME METHODS FOR UNEXPECTED RED CELL ANTIBODY SCREENING AND IDENTIFICATION

J.N. Lee, J.H. Shin, J.Y. Lee, J.H. Kim, H.R. Kim (Busan Paik Hospital, Inje University, Busan, South-Korea)

P-065 BLOOD TRANSFUSION IN PATIENTS WITH RARE BLOOD GROUP – A TAIWAN EXPERIENCE

M.L. Lin (Mackay Memorial Hospital, Tan-sui, Taipei County, Taiwan)

P-066 INCIDENCE OF RED CELL ALLOANTIBODIES IN A MULTI-ETHNIC HOSPITAL PATIENT POPULATION

S.N. Nadarajan, A.A. Hlaing, T.H. Maung, I. Jeyajoti, T.N. Kyu, K.J. Ranjana, A.A. Myint (University Malaya Medical Centre, Kuala Lumpur, Malaysia)

P-067 COMPARATIVE EVALUATION OF THE PERFORMANCE OF GRIFOLS DG GEL® CARDS VERSUS DIAMED ID-CARDS IN ANTIGEN DETERMINATION OF ABO, D ANTIGEN AND IRREGULAR ANTIBODIES INVESTIGATION

R.C. O’Chareon, M. Aimtip, W. Manakul, P. Kupatawintu (Thai Red Cross Society, Bangkok, Thailand)

P-068 SIGNIFICANCE OF LEWIS PHENOTYPING USING SALIVA AND GASTRIC TISSUE: COMPARISON WITH THE LEWIS PHENOTYPE INFERRED FROM LEWIS AND SECRETOR GENOTYPES

K.U. Park, E.Y. Song, J. Song, K.S. Han (Seoul National Univ Bundang Hospital, Seongnam-si, Gyeonggi-do, South-Korea)

P-069 FIRST CZECH CASE OF K(NULL) PHENOTYPE - SEROLOGIC CHARACTERISTICS AND GENETIC BASIS

M. Pisacka, M. Kralova, D. Galuszkova, J. Poole, V. Crew, A. Wilkes (Inst. Haematology & Blood Transfusion, Prague 2, Czech Republic)

P-070 NAT TESTING EXPERIENCE

S.S.S. Sharma (Excel Biosystems, Delhi, India)

P-071 ESTABLISHMENT AND CHARACTERIZATION OF HUMAN MONOCLONAL ANTI-LAN

Y. Tani, H. Takahashi, M. Hirashima, H. Tominaga, H. Sakamoto, K. Sugimoto, M. Horie, J. Takahashi, T. Nakade, M. Taniguchi, Y. Takaku, H. Matsukura, F. Hirayama, H. Shibata (Japanese Red Cross Osaka Blood Center, Osaka, Japan)

P-072 DETECTION OF RED CELL ALLOANTIBODY IN REGULAR BLOOD DONORS IN HOSPITAL UNIVERSITI SAINS MALAYSIA

W.H. Wan Mahmood, M. Ramli, N. Mohd Noor, S. Mohd Yusoff, R. Bahar, S. Sukri (School of Medical Sciences, Kubang Kerian, Malaysia)

P-073 A STUDY OF ABO SUBGROUPS AMONG CHINESE OF SHANGHAI

D. Xiang, X. Liu, Z.H. Guo, X.Y. Zhou, J.M. Zhang, W. Shen (Shanghai Blood Center, Shanghai, China)

P-074 I BRANCHING FORMATION IN ERYTHROID DIFFERENTIATION IS REGULATED BY TRANSCRIPTION FACTOR C/EBPA

L.-C. Yu, Y.-C. Twu (National Taiwan University, Taipei, Taiwan)

Models of Increased Safety Measures

P-075 INACTIVATION OF LYMPHOCYTE BY RIBOFLAVIN PHOTOSENSITIZATION

Z. Cui, Q. Mo, Y. Huang, K. Qian (Shanghai Blood Center, China, Shanghai, China)

P-076 INVESTIGATE THE EFFECT ON BLOOD COMPONENTS AFTER 137CS-IRRADIATION

Y. Liu, H.H. Fan (Shanghai Blood Center, Shanghai, China)

P-077 ELECTRONIC CROSSMATCH AND PATIENT’S SAFETY

E.M. Merdanogullari, F. Cetinkaya (Haydarpasa Numune, Istanbul, Turkey)

P-078 THE EFFECT OF PRESTORAGE FILTERATION ON PLATELET ACTIVATION IN PLATELET CONCENTERATES

A. Solaimany Ferizhandy, M. Agheepor, A. Pourfathollah (Iranian Blood Transfusion Organization, Tehran, Iran)

P-079 HEMORHEOLOGIC EVALUATION OF ANTI-OXIDANT TREATED RED BLOOD CELLS ON GAMMA-RAY IRRADIATION

J.S. Suh, Y.K. Kim, D.I. Won, D.H. Kim, E.H. Kwon, S. Shin (Kyungpook National University, Daegu, South-Korea)

P-080 THE RATIONAL USE OF HOMOLOGOUS BLOOD IN ORTHOPEDIC PATIENTS

V. Urlep Salinovic, B. Majcen Vivod, B. Bizjak, L. Lokar (Teaching Hospital, Maribor, Slovenia)

P-081 CHARACTERISTICS OF VIRUS INACTIVATED THERAFLEX MB-PLASMA

W.H. Walker, S. Reichenberg, U. Gravemann, P. Pohler (MacoPharma International GmbH, Langen, Germany)

P-082 A NOVEL TECHNIQUE FOR PATHOGEN INACTIVATION AND ITS EFFECT ON THE QUALITY OF PLATELET CONCENTRATES: THERAFLEX UV PLATELETS

W.H. Walker, F. Tolksdorf, U. Gravemann, H. Mohr, T.H. Mueller (MacoPharma International GmbH, Langen, Germany)

Expanding the Role of Blood Banks / Hospitals

P-083 CHANGES IN TRANSFUSION PRACTICES OVER 5 YEARS

F. Danielson, E. Cuculick, A. Kelick, J. Parks (Indiana University Medical Center, Indianapolis , In, USA)

P-084 THE ESTABLISHMENT OF FROZEN BLOOD BANK OF RARE BLOOD GROUP IN GUANG-XI AREA OF CHINA AND ITS CLINICAL SIGNIFICANCE

Q.H Mo, Q.M. Tang, W.D. Shen, B.R. He, Y. Zhou (Nanning Blood Bank, Nanning, China)

Platelets Transfusion

P-085 EVALUATION OF PLATELET TRANSFUSION TRIGGERS IN A REFERRAL HOSPITAL IN TURKEY

FC Cetinkaya, E. Merdanogullari (Haydarpasa Numune, Istanbul, Turkey)

P-086 POLYMORPHISM OF THE HUMAN PLATELET ALLOANTIGENS HPA-3 AND HPA-9W IN THE CHINESE HAN POPULATION

M.L. Feng, H. Huang, T. Shen, D.Z. Liu (Shanghai Blood Center, Shanghai, China)

P-087 CD133+ CELLS AS AN ALTERNATIVE SOURCE FOR PLATELET PRODUCTION

A. Goodarzi, M. Kheirandish, A. Noroozi, F. Khojaknejad, E. Hajati, F. Razzazian, V. Farahat (Iranian Blood Transfusion, Tehran, Iran)

P-088 AN ASSOCIATION OF SOLUBLE CD40 LIGAND WITH POST TRANSFUSION PLATELET INCREMENT

I. Lee, S.Y. Kang, S.Y. Cho, H.S. Park, E.H. Choi (Kyung Hee East West Neo Medical Center, Seoul, South-Korea)

P-089 FREQUENCY DISTRIBUTION OF HUMAN PLATELET ANTIGENS IN GUANGXI POPULATION OF CHINESE

Y. Liao, W.D. Shen, G.G. Wu, Q.M. Tang, H.C. Li, B.R. He, Y. Zhou, D.Y. Huang, Q.H. Mo (Nan-Ning Institute of Transfusion Medici, Nan-ning, China)

P-090 ESTIMATION OF PLATELET ACTIVATION MARKERS USING FLOW CYTOMETRY IN PATIENTS WITH HEMATO-ONCOLOGIC DISORDERS AFTER TRANSFUSION

Y.A. Lim, S.R. Cho, W.G. Lee, J.S. Park, S.W. Kim (Ajou University, School of Medicine, Suwon, South-Korea)

P-091 BIOCHEMICAL LESIONS IN POOLED-PLATELETS STORED FOR 5 DAYS

M. Mahmoodian Shooshtari, A. Dawatgar, M. Aghai pour, Z. Sharifi, A. Talebian (Research Center of Blood Transfusion Centre, Tehran, Iran)

P-093 PAIRED COMPARISON OF DOUBLE DOSE PLATELET COLLECTION FROM TWO APHERESIS INSTRUMENTS

S.N. Nadarajan, T.N. Kyu, T.H. Maung, A.A. Hlaing, A.A. Myint, I. Jeyajoti, K.J. Ranjana (University Malaya Medical Centre, Kuala Lumpur, Malaysia)

P-094 THE PLATELET AGGREGATION IN HYPERTENSIVE PATIENTS WITH TARGET DAMAGE

N. Nguyen (NIHBT, Hanoi, Vietnam)

P-095 STORAGE RELATED CYTOKINE LIBERATION IN MIRASOL-PRT TREATED APHERESIS PLATELETS COMPARED TO UNTREATED AND IRRADIATED UNITS COLLECTED FROM THE SAME DONORS

S.M. Picker, A. Steisel, B.S. Gathof (University of Cologne, Cologne, Germany)

P-096 THE EFFECT OF GAMMA IRRADIATION ON LYMPHOCYTE PROLIFERATION AND IL-8 PRODUCTION BY LYMPHOCYTES ISOLATED FROM PLATELET CONCENTRATES

A. Pourfathollah, M. Shaiegan, M. Namiri, Z. Aghaei (Tarbiat Modares University, Tehran, Iran)

P-097 EVALUATION OF THE CORRECT USE OF VIRCON DISINFECTANT IN REDUCING BACTERIAL CONTAMINATION OF PLATELETS COMPONENTS PREPARED IN TEHRAN BLOOD CENTER WITHIN FIRST HALF OF 2005

M. Sadeh (Fayazbakhsh hospital (S.S.O), Tehran, Iran)

P-098 SEASONS HAVE NO EFFECTS TO THE PLATELET TRANSFUSION IN YOGYAKARTA INDONESIA

T. Triyono, S.A. Sahidu (Sardjito Hospital/ Faculty of Medicine, Yogyakarta, Indonesia)

P-099 PLATELET ALLOIMMUNIZATION DUE TO PLATELET-REACTIVE ANTIBODIES IN PATIENTS SHOWING PLATELET REFRACTORINESS FOLLOWING MULTIPLE PLATELET TRANSFUSIONS

D. Sen, K. Chatterjee, R. Thapliyal (Armed Forces Transfusion Centre, New Delhi, India)

P-101 EFFECTS OF SEASONS TO PLATELET TRANSFUSION IN YOGYAKARTA INDONESIA

S. Sitti Aisyah Sahidu, T. Triyono (Sardjito Hospital, Yogyakarta, Indonesia)

P-102 COMPARSION OF PLATELET CONCENTRATES DURING STORAGE IN ADDITIVE SOLUTION AND PLASMA

D. Sredzinski, A. Lipska, P. Radziwon (Regional Centre for Transfusion Medicine, Bialystok, Poland)

P-103 ROLE OF PLATELET TRANSFUSION IN DENGUE HEMORRHAGIC FEVER

T. Triyono, U. Sukorini, S. Pramono (Sardjito Hospital/ faculty of Medicine., Yogyakarta, Indonesia)

P-104 THE EFFECT OF PLASMA IN ADDITIVE SOLUTION ON THE QUALITY IN VITRO OF PLATELET CONCENTRATES STORED AT 4°

R.F. Xie, F.F. Cao, H.H. Fan, X. Zhang, Y. Liu, L. Gao, K.C. Qian (Shanghai Blood Centre, Shanghai, China)

Blood Donor Recruitment

P-105 EVALUATION OF AWARENESS OF BLOOD DONORS EXPOSED TO EDUCATIONAL MATERIALS ABOUT SAFE BLOOD DONATION IN TABRIZ IN 2005

Sh. Ilbeigi, A. Gharebaghian, A. Moghadam, R. Dehkhoda, H. Sarvi, F. Zoghi, A. Hossein Pour (IBTO Research Center, Tehran, Iran)

P-106 EVALUATION OF WHOLE BLOOD DONOR DEFERRAL RATE AND REASONS AT YAZD BLOOD TRANSFUSION CENTER

H. Javadzadeh Shahshahani (Researh Center of Iranian BTO, Yazd, Iran)

P-107 INCREASING OF THE NUMBER OF VOLUNTEERS WITH CONSTANT MOTIVATION ON FI ELD

E. Kocovska, T. Timova, T. Momiroska (General Hospital Tetovo, Tetovo, Macedonia)

P-108 DONOR DEFERRAL IN A LARGE MOBILE BLOOD DONATION PROGRSMME IN SRI LANKA

W.W.K. Perera (National Blood Centre, Colombo-5, Sri Lanka)

P-109 COMMUNICATING THE NEED FOR BLOOD

B. Petrovic (University of Belgrade, Beograd, Serbia)

P-110 A RETROSPECTIVE STUDY OF REJECTED DONORS IN HOSPITAL ALOR STAR (JAN-JUNE 2004)

P. Puspanathan, H. Hashim, A.R. Mohd Ibrahim (Hospital Alor Setar, Alor Setar, Malaysia)

P-111 IS RAISING THE MINIMUM HEMOGLOBIN REQUIREMENT THE SOLUTION TO IMPROVING THE IRON STATUS OF DONORS?

J.N. Shah, H.H. Tan, D. Teo (Health Sciences Authority, Singapore, Singapore)

P-112 SOCIO-DEMOGRAPHIC PROFILE AND MOTIVATIONS OF PHILIPPINE HEART CENTER BLOOD DONORS

K. Sia, M. Orillaza, L. Sagun (Philippine Heart Center, Quezon City, Philippines)

P-113 EFFECT OF CHANGES IN DONOR SELECTION CRITERIA ON BLOOD COLLECTION

H.H. Tan, J. Chay (Health Sciences Authority, Singapore, Singapore)

P-114 KNOWLEDGE AND ATTITUDE TOWARDS VOLUNTEER BLOOD DONATION AMONG PUBLIC IN KOTA BHARU

W.H. Wan Mahmood, R. Hassan, N.S. Che Soh (School of Medical Sciences, Kubang Kerian, Malaysia)

Transfusion Practice in Specific Clinical Situations

P-115 EVALUATION OF FRESH FROZEN PLASMA TRANSFUSION PRACTICES IN KOREAN HOSPITAL

S.Y. Cho, W.I. Lee, S.Y. Kang, S.Y. Park, K.S. Park (East-West Neo Medical Center, Seoul, South-Korea)

P-116 CAN TRANSFUSION OF ABO INCOMPATIBLE PLASMA CAUSE A SEVERE ALLERGIC REACTION?

F. Danielson, E. Cuculick, A. Kelick, J. Parks, D. Waxman (Indiana University Medical Center, Indianapolis , In, USA)

P-117 EFFICIENCY OF TRANSFUSION OF DEPLASMATIZED ERYTHROCYTES IN PATIENTS WITH HEMATOGENIC OLIGEMY

B. Gavrancic, T. Jakica (Medical Faculty, Novi Sad, Serbia)

P-118 SYNDROME OF MASSIVE TRANSFUSION

C. Gavrancic (Blood Transfusion Institute, Novi Sad, Serbia)

P-120 ASSESSMENT OF THYROID FUNCTION IN MULTI-TRANSFUSED THALASSEMIA PATIENTS

F. Jalali Farahani, S. Zolfaghari Anaraki, A. Talebian, M. Maghsudlu, A. Azarkeivan, M. Sarmadi, A. Shahrabi, Z. Taherkhani (Iranian Blood Transfusion Research Cente, Tehran, Iran)

P-121 RH D ALOIMUNIZATION DURING THE FIRST PREGNANCY

V. Jovanoska, I. Jovanoski (JZU General Hospital, Prilep, Macedonia)

P-122 RETROSPECTIVE STUDY ON EFFICIENCY OF RED BLOOD CELL TRANSFUSION IN FOUR CITIES

Y.L. Lv., H.F. Nie, Q.L. Xu, J.F. Zhang, Q. Ding (Luo Yang Blood Center, Luo Yang, China)

P-123 USE OF BLOOD COMPONENTS IN CRITICALLY ILL PATIENTS IN THE MEDICAL INTENSIVE CARE UNIT OF A TERTIARY CARE HOSPITAL

R.N. Makroo, R.K. Mani, V. Raina, S. Kansal, P. Kumar, S. Tyagi (Indraprastha Apollo Hospitals, New Delhi, India)

P-124 TREATING PANCREAS MALGN ANEMIA

M. Momiroska (Pablik Hospital, Prilep, Macedonia)

P-125 HYPERHAEMOLYSIS IN A PATIENT WITH ?-THALASSAEMIA MAJOR

R.L. Morawakage (National Blood centre, Colombo, Sri Lanka)

P-126 IN-VITRO HAEMOSTATIC EFFECTS OF A TRADITIONAL MEDICINE PRODUCT CALLED THE REMEDY NO.2 FOR DENGUE HEMORRHAGIC FEVER (DHF)

T. Nguyen, H. Nguyen Thi, K. Ly, C. Nguyen, B. Dang Thi, T. Vuong Thi (Central Military Hospital 108, Ha Noi, Vietnam)

P-127 A PRILIMINARY STUDY ON THERAPEUTIC PLASMA EXCHANGE FOR COMMON CLINICAL INDICATIONS AND ITS SUCCESS IN NATIONAL HOSPITAL SRI LANKA

R.D. Ramanayaka (National Blood Transfusion Service, Colombo, 05, Sri Lanka)

P-128 MANAGEMENT IN PROVIDING COMPATIBLE BLOOD FOR A POLITRANSFUSED PATIENT WITH GIANT RECKLINGHANSEN TUMOR

E. Sirian, I. Radulian, O. Vuculescu, N. Vladareanu (National Institute of Transfusion Haemat, Bucharest, Romania)

P-129 THERAPEUTIC PLASMA EXCHANGE IN LIVER FAILURE (A CASE REPORT)

N. Solaz, M. Karaca, V. Arslan, C. Gencturk, F. Donmez, A. Kemahli, A. Kemahli (Ankara University, Ankara, Turkey)

Safety of Cells and Tissues and its Donors

P-130 EVLUATION OF SERUM LEVELS OF C3, C4, ANTI-DNA AND ANTI - NUCLEAR ANTIBODIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

M. Aghaeipour, F. Tarabadi, M. Shaiegan, S. Dootdar, G. Babaee (Iranian Blood Transfusion Research Centre, Tehran, Iran)

P-131 COMPARISON OF THE PERFORMANCE OF SCANGEL AND TUBE TECHNIQUES IN CROSS MATCH TEST IN JAKARTA

N.S.I. Hippy (Central Blood Transfusion Service, Jakarta, Indonesia)

P-132 PRESENT STATUS OF KEIHAN CORD BLOOD BANK IN JAPANESE CORD BLOOD BANK NETWORK-THE NUMBER OF THE CELLS IN PRESERVED CORD BLOOD UNITS HAS MOSTLY EXCEEDED 10E9

M. Kohsaki, K. Matsumoto, H. Fujii, H. Shibata (Kitaosaka Red Cross Blood Center, Ibaraki, Japan)

P-133 TO THE REGULATION AND PROMOTION THE CONSERVATION OF CORD BLOOD STEM CELLS FOR ALLOGENIC TRANSPLANTATION IN ARGENTINA. SPECIAL REFERENCE TO THE INFORMED CONSENT

A. Krasnow, R. Di Tullio Budassi (Conicet-Universidad Nacional de Rosario, Rosario, Argentina)

Haemovigilance in Patients

P-134 TRANSFUSION-RELATED INFECTIOUS DISEASES REPORTED TO JAPANESE RED CROSS BLOOD CENTERS IN 2004-2006

S. Momose, R. Taira, T. Numoto, A. Ito, N Goto, H Yugi, S Hino, K Tadokoro (Japanese Red Cross Society, Tokyo, Japan)

P-135 LABORATORY APPROACH TO DIAGNOSIS OF HEMOLYTIC TRANSFUSION REACTION

S. Mortazavi Rashtchi (Lale Hospital, Tehran, Iran)

P-136 HEMOVIGILANCE - FIVE YEARS ANALYSIS OF ADVERSE EVENTS IN PATIENTS IN TEACHING HOSPITAL MARIBOR

V. Urlep Salinovic (Teaching Hospital, Maribor, Slovenia)

Quality Management

P-137 SHOULD APPROPRIATENESS OF TRANSFUSION BE MONITORED USING POST VS. PRE-TRANSFUSION HEMOGLOBIN LEVELS?

F. Danielson, E. Cuculick, A. Kelick, J. Parks, D. Wilhite (Indiana University Medical Center, Indianapolis , In, USA)

P-138 QUALITY MANAGEMENT SYSTEM IN BLOOD TRANSFUSION INSTITUTE OF VOJVODINA

R. Jovanovic (Blood Transfusion Institute of Vojvodina, Novi Sad, Serbia)

P-139 EXTERNAL QUALITY ASSESSMENT ON BLOOD GROUP TESTING IN CHINESE TRANSFUSION LABORATORY

W Shen, J.L. Wang, D Xiang, S. Jin, D.Z. Liu, Z.Y. Zhu (Shanghai Blood Center, Shanghai, China)

P-140 ISO 15189 AND THE IMPROVEMENT OF BLOOD TRANSFUSION SERVICES IN BINH DINH PROVINCE VIETNAM

P.H. Skidmore, L. McMillan, V.Th. Ngyuen, V.D. Loc, Ph.Th. Huong (New Zealand - Vietnam Health Trust, Christchurch, New Zealand)

Hemophilia

P-141 HEMOPHILIA PROFILE IN JAKARTA: BETWEEN THE ESTIMATION AND REALITY

N.S.I. Hippy (Central Blood Transfusion Service, Jakarta, Indonesia)

P-142 EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS OF HEMOPHILIA POPULATION IN NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION

N.T. Mai, N.A. Tri, N.T. Nu, P.Q. Hoa, H.T. Thanh (National Institute of Hematology and Blo, Hanoi, Vietnam)

P-143 COAGULANT BALANCE DISORDERS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND DISLIPEMIA

N. Nguyen (NIHBT, Hanoi, Vietnam)

P-144 NATIONAL POLICY ADOPTED BY IRANIAN GOVERNMENT TOWARD PREVENTING AND TREATMENT OF HEMOPHILIA

H. Rezaei Ghaleh (Iranian Charity Foundation for Special D, Tehran, Iran)

New Trends in Transfusion Medicine Science

P-145 EVALUATION AND COMPARISON OF TWO PRE-TRANSFUSION TESTING INSTRUMENTS, THE AUTOVUE INNOVA (ORTHO, RARITAN, NJ) AND THE TECHNOTWIN STATION (DIAMED AG, CRESSIR SUR MORAT, SWITZERLAND)

S.H. Koo, S.Y. Shin, K.C. Kwon, C.S. Ko, J.H. Song, J.W. Park (Chungnam National University Hospital, Daejeon, South-Korea)

P-146 AUTOMATION IN IMMUNOHEMATOLOGY LABORATORY WITH ORTHO AUTOVUE INNOVA

S.H. Lee, J. Jeong, U.S. Jeong, T.W. Kim, Y.J. Jeong, J.H. Wee, S.R. Kim (Ulsan University Hospital, Ulsan, South-Korea)

P-147 STUDY OF HLA POLYMORPHISM BETWEEN ZHUANGS’ AND HANS’ DONORS IN THE GUANGXI BONE MARROW REGISTRY

H.C. Li (Nanning Institute of Transfusion Medicine, Nanning, China)

Late Submitted Abstracts

P-148 THE BLOODSAFE PROGRAM: IMPROVING THE SAFETY AND QUALITY OF HOSPITAL TRANSFUSION PRACTICE.

D.M. Peterson, K. Robinson, T. Verrall, B. Quested, B. Parker, R. Hunt, T. Roberts, T. Roffey (BloodSafe, Adelaide, Australia)

P-149 A RAPID METHOD SEPARATION OF SENSITIZED AND NON-SENSITIZED RBCS: SEPHADEX-BASED CELL-AFFINITY ADSORBENTS

L. Liu, W. Wang (Dongguan Blood Center, Dongguan, China)

P-150 OIL BLOOD CHALLENGE CUP

L. Willdigg (Aberdeen & North East BTS, Aberdeen, United Kingdom)

P-151 SURVEY FOR FINDING THE REASONS OF DISCREPANCY IN BLOOD GROUPS (BACK TYPE & CELL TYPE) IN TEHRAN

M. Selseleh, F. Yazdani., Y. Esmaili (Tehran Province Blood Transfusion Center, Tehran, Iran)

P-152 EFFECT OF ME2SO ON PRE-TREATMENT PLATELETS BEFORE FREEZE-DRYING

F.Q. Lu, S.G. Zhao, Y.Q. Yang, Y. Peng (Central Blood Station of Tong Zhou District, Beijing, China)

P-153 PROCESS OF HUMAN PLATELETS LOADED WITH TREHALOSE BEFORE FREEZE-DRYING

F.Q. Lu (Central Blood Station of Tong Zhou, Beijing, China)

P-154 EXPERIMENTAL STUDY OF AGGREGATION AND ACTIVATION IN POOLED BUFFY COAT-DERIVED AND APHERESIS PLATELETS

F.Q. Lu (Central Blood Station of Tong Zhou, Beijing, China)

P-155 A LARGE ANIMAL MODEL OF TRALI: A COMPARISON OF THE OXIDATIVE RESPONSES OF OVINE AND HUMAN NEUTROPHILS

Y.L. Fung., J.P. Tung., P. Wood, M. Wullschleger, K. Wilson, J. Fraser (Australian Red Cross Blood Service, Brisbane, Australia)

P-156 KO PHENOTYPE CASE REPORT

Y.F. Kuo, L. Li, C.H. Lai, S.J.Lin, K.S. Lin (Taipei Blood Center, Taiwan Blood Services Foundation, Taipei, Taiwan)

P-157 HEMOPHAGOCYTOSIS IN THE PERIPHERAL BLOOD WITH COLD AGGLUTININ AUTOIMMUNE HEMOLYTIC ANEMIA

P.V. Holland, P. Starshak, M. McNamara, K. Janatpour, D. Dwyre (UC Davis Medical Center, Sacramento, USA)